We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

311 hedge funds and large institutions have $3.72B invested in Editas Medicine in 2020 Q4 according to their latest regulatory filings, with 104 funds opening new positions, 87 increasing their positions, 69 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

235% more first-time investments, than exits

New positions opened: 104 | Existing positions closed: 31

140% more capital invested

Capital invested by funds: $1.55B → $3.72B (+$2.17B)

40% more call options, than puts

Call options by funds: $188M | Put options by funds: $134M

30% more funds holding

Funds holding: 239 → 311 (+72)

26% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 69

3.56% less ownership

Funds ownership: 88.57% → 85.02% (-3.6%)

Holders
311
Holders Change
+72
Holders Change %
+30.13%
% of All Funds
5.5%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
104
Increased
87
Reduced
69
Closed
31
Calls
$188M
Puts
$134M
Net Calls
+$53.9M
Net Calls Change
+$35M

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$16.8M
2
Voloridge Investment Management
Voloridge Investment Management
Florida
+$16.7M
3
GLA
Great Lakes Advisors
Illinois
+$15.6M
4
SOMRS
State of Michigan Retirement System
Michigan
+$12.6M
5
JP Morgan Chase
JP Morgan Chase
New York
+$5.13M

Top Sellers

Rank Fund Capital Flow
1
NAMA
Nikko Asset Management Americas
New York
-$28.2M
2
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$28.2M
3
State Street
State Street
Massachusetts
-$26.4M
4
AIM
ARK Investment Management
Florida
-$22.4M
5
DM
Deerfield Management
New York
-$18.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
VEA
176
Virtus ETF Advisers
New York
$336K -$272K -6,619 -58%
HS
177
Haafor (Singapore)
Singapore
$334K +$196K +4,761 New
LDFR
178
Lehman & Derafelo Financial Resources
Pennsylvania
$319K +$57.5K +1,400 +44%
PFS
179
Prospera Financial Services
Texas
$304K +$178K +4,334 New
M&T Bank
180
M&T Bank
New York
$296K -$288K -7,022 -62%
AFA
181
Arlington Financial Advisors
California
$294K +$173K +4,200 New
ECM
182
ExodusPoint Capital Management
New York
$293K -$1.76M -42,843 -91%
Canada Life
183
Canada Life
Manitoba, Canada
$291K – – –
MML Investors Services
184
MML Investors Services
Massachusetts
$289K +$169K +4,124 New
JMPWA
185
JP Morgan Private Wealth Advisors
California
$289K +$170K +4,128 New
OIA
186
OneDigital Investment Advisors
Kansas
$287K +$168K +4,094 New
SPC
187
Sigma Planning Corp
Michigan
$283K +$166K +4,038 New
WS
188
Wedbush Securities
California
$283K +$166K +4,040 New
Squarepoint
189
Squarepoint
New York
$282K -$750K -18,259 -82%
Toronto Dominion Bank
190
Toronto Dominion Bank
Ontario, Canada
$280K – – –
LSA
191
L & S Advisors
California
$280K +$164K +4,000 New
VFA
192
Valeo Financial Advisors
Indiana
$273K – – –
PL
193
Plancorp LLC
Missouri
$264K +$155K +3,765 New
Mercer Global Advisors
194
Mercer Global Advisors
Colorado
$255K +$150K +3,644 New
DIM
195
DC Investments Management
Virginia
$254K +$149K +3,627 New
GIA
196
Gladstone Institutional Advisory
Florida
$251K +$147K +3,575 New
BWM
197
Buckley Wealth Management
Nevada
$245K +$144K +3,500 New
CIC
198
Carnegie Investment Counsel
Ohio
$244K +$143K +3,479 New
FAB
199
First American Bank
Illinois
$241K +$141K +3,439 New
Walleye Trading
200
Walleye Trading
New York
$225K +$15.2K +369 +13%
6 7
8
9 10

EDIT Hedge Fund Activity: Q4 2020 in Review

311 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2020, worth a combined $3.72B — up 140% from $1.55B a quarter earlier.

Buyers outnumbered sellers: 104 funds opened new EDIT positions and 31 closed out — a net gain of 73 holders — while 87 added to existing stakes and 69 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $16.8M. The largest seller was Nikko Asset Management Americas, cutting an estimated $28.2M.

  • 311 institutional investors held Editas Medicine (EDIT) as of Q4 2020, up from 239 in Q3 2020.
  • Funds reported $3.72B of Editas Medicine stock for Q4 2020, up 140% quarter-over-quarter.
  • 104 funds opened new Editas Medicine positions in Q4 2020 and 31 closed out, a net change of +73 holders.
  • The largest Editas Medicine buyer in Q4 2020 was D.E. Shaw & Co, an estimated $16.8M added.
  • The largest Editas Medicine seller in Q4 2020 was Nikko Asset Management Americas, an estimated $28.2M sold.

Based on aggregated 13F filings for Q4 2020.